Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
1 other identifier
interventional
44
1 country
2
Brief Summary
Disturbed sleep is stressful to persons living with dementia (PLwD) and their caregivers. It contributes to earlier placement of the PLwD in nursing homes and increase the risk for many psychological and cognitive health issues and poor quality of life for both the PLwD and the caregivers. Given the potential harmful side effects of medications, non-medication alternatives, such as Cognitive Behavioral Therapy for Insomnia (CBTi), may be safer to improve disturbed sleep in this population. CBTi which includes stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring, is effective and has durable and sustained effects on sleep outcomes over the long-term. CBTi has improved sleep disturbances in PLwD and their caregivers, separately. Since disturbed sleep in the PLwD-caregiver dyad is bidirectional and interdependent, targeting the pair as a unit for intervention has the potential to lead to improved sleep and health outcomes for both persons. There is no current published research on CBTi when the PLwD and their caregivers receive the intervention at the same time; as a result, the researchers will examine the 1) feasibility; 2) acceptability; and 3) preliminary efficacy of 4-week CBTi intervention for community-dwelling PLwD and their caregivers who are both experiencing sleep disturbances. Forty PLwD-caregiver dyads will receive CBTi via videoconferencing sessions. Preliminary efficacy of the intervention will be assessed using objective (actigraphy) and subjective sleep quality measures. In addition, semi-structured interviews will be conducted to examine the acceptability and satisfaction with the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedStudy Start
First participant enrolled
September 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2023
CompletedMarch 20, 2023
March 1, 2023
2.4 years
June 9, 2020
March 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Adherence with Study Interventions
Feasibility of the interventions will be assessed with rates of adherence to the study components weekly and over the 4 weeks
Weeks 1, 2, 3, 4
Percent Attrition from the Study
Feasibility of the interventions will be assessed with the percent of participants leaving the study over the 4 week intervention.
Week 4
Acceptability the Intervention
Acceptability of the interventions will be assessed with a qualitative interview with caregivers after completing the intervention. There is not a summary score for the open-ended questions asked during the interview.
Week 5 (1 week post-intervention)
Secondary Outcomes (12)
Change in Sleep Disorders Inventory (SDI) - Frequency Score
Baseline, Week 5 (1 week post-intervention), Month 4 (1 month post-intervention)
Change in Sleep Disorders Inventory (SDI) - Severity Score
Baseline, Week 5 (1 week post-intervention), Month 4 (1 month post-intervention)
Change in Sleep Disorders Inventory (SDI) - Caregiver Distress Score
Baseline, Week 5 (1 week post-intervention), Month 4 (1 month post-intervention)
Change in Insomnia Severity Index Score
Baseline, Week 5 (1 week post-intervention), Month 4 (1 month post-intervention)
Change in 12-Item Short Form-12 (SF-12v2) Health Survey Score
Baseline, Week 5 (1 week post-intervention), Month 4 (1 month post-intervention)
- +7 more secondary outcomes
Study Arms (2)
PLwD Cognitive Behavioral Therapy for Insomnia (CBTi)
EXPERIMENTALPersons living with dementia in a dyad receiving the CBTi intervention in a videoconferencing format.
Caregiver Cognitive Behavioral Therapy for Insomnia (CBTi)
EXPERIMENTALCaregivers in a dyad receiving the CBTi intervention in a videoconferencing format.
Interventions
The CBTi protocol will include stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring which will be done over 4 weeks with one session weekly delivered via videoconference.
Eligibility Criteria
You may qualify if:
- Caregiver-reported diagnosis of cognitive impairment and Alzheimer's disease and related dementias (ADRD)
- Co-residence with the caregiver in the community
- Montreal Cognitive Assessment (MOCA) score between 12 and 25
- Stable dose of psychotropic medications, anti-dementia, sedatives/hypnotics, or opioids in the past 90 days
- Presence of sleep problems determined by using the proxy-rated Sleep Disorders Inventory (presence of at least one sleep disturbance symptom of moderate severity)
- Informal caregivers (family/friends) of co-residing PLwD
- Providing unpaid assistance, on average 20 hours weekly, for a person in the early stage of illness who is community-dwelling
- Presence of sleep problems: sleep onset latency or wake after sleep onset more than 30 minutes more than 3 nights weekly
- Tolerate and agrees to wear wrist actigraph
- Be able to read, speak and understand English
- Have no uncorrectable vision or hearing deficits that might impede participation
You may not qualify if:
- None
- Moderate to severe cognitive impairment defined as MoCA score \<17
- Current sedative-hypnotic or other sleep aid use on a regular or as needed schedule within the prior three months
- Presence of an acute medical or psychiatric condition which would interfere with the subject's ability to realistically follow the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Alzheimer's Associationcollaborator
Study Sites (2)
Emory University
Atlanta, Georgia, 30322, United States
Goizueta Alzheimer's Disease Research Center
Atlanta, Georgia, 30329, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glenna Brewster, PhD, RN
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 9, 2020
First Posted
June 11, 2020
Study Start
September 30, 2020
Primary Completion
March 10, 2023
Study Completion
March 10, 2023
Last Updated
March 20, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share